Drawing for HYC

USPTO serial 97428038

HYC

Reviewed by CopyMark Law Group

Reg. 7179682Status 700Registered
Filing date
Status date
Registration date
Oct 3, 2023
Examiner
RINKER, ANTHONY MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HYC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kumiko Ide

Kumiko Ide WENDEROTH, LIND & PONACK, L.L.P.1025 CONNECTICUT AVENUE NW, SUITE 500WASHINGTON, DE 20036United States

Goods and services

ClassDescriptionStatusFirst use
001Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic syndrome, obesity, lipid disorder, hypertension, hyperglycemia, inflammatory disorder, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, lung inflammation, articular inflammation, skin inflammation, nerve inflammation related diseases and cancers resulting from chronic inflammation, urethritis, cystitis, pyelonephritis, nephritis, ocular inflammation, intestinal disease, dental problem and oral disease, namely, periodontal diseases, stomatitis, xerostomia and cyst, and pharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of wrapping wafers for medicine doses; gauze for dressings; capsules sold empty for pharmaceuticals; eye patches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid medical dressings; liquid dressings for wounds, burns and surgery; breast-nursing pads; dental composite, impression and porcelain materials; dental materials, namely, dental porcelain materials, materials for making dental impressions and composite materials for dental and dental technical purposes; dietetic food, namely, dietary supplements for human consumption; dietary supplements for medical purposes for improving metabolic function, suppressing inflammation, protecting intestinal tracts and improving oral environment; dietary supplements for animalsACTIVE—
004Solid lubricants for industrial purposes; grease for shoes and boots; leather preserving oil and grease; solid fuels; liquid fuels; gaseous fuels; mineral oils and greases for industrial purposes not for fuel; non-mineral oils and greases for industrial purposes not for fuelACTIVE—
005Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic syndrome, obesity, lipid disorder, hypertension, hyperglycemia, inflammatory disorder, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, lung inflammation, articular inflammation, skin inflammation, nerve inflammation related diseases and cancers resulting from chronic inflammation, urethritis, cystitis, pyelonephritis, nephritis, ocular inflammation, intestinal disease, dental problem and oral disease, namely, periodontal diseases, stomatitis, xerostomia and cyst, and pharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of wrapping wafers for medicine doses; gauze for dressings; capsules sold empty for pharmaceuticals; eye patches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid medical dressings; liquid dressings for wounds, burns and surgery; breast-nursing pads; dental composite, impression and porcelain materials; dental materials, namely, dental porcelain materials, materials for making dental impressions and composite materials for dental and dental technical purposes; dietetic food, namely, dietary supplements for human consumption; dietary supplements for medical purposes for improving metabolic function, suppressing inflammation, protecting intestinal tracts and improving oral environment; dietary supplements for animalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 3, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2023ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Aug 8, 2023CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Aug 8, 2023APETASSIGNED TO PETITION STAFF—
Jul 25, 2023EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
May 9, 2023ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 18, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 18, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 15, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 15, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 15, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 15, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 13, 2023DOCKASSIGNED TO EXAMINER—
Jun 1, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 28, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance